Quantification of perineural cancer invasion on systematic needle core biopsy of the prostate is useful for risk stratification in patients with Grade Group 2 or 3 cancer, but not in those with Grade Group 4-5 cancer

被引：0
|
作者：
Teramoto, Y. [1 ]
Wang, Y. [1 ]
Miyamoto, H. [2 ]
机构：
[1] Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY USA
[2] Univ Rochester, Med Ctr, Dept Pathol & Urol, Rochester, NY USA
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0288
引用
收藏
页码：S1080 / S1081
页数：2
相关论文
共 50 条
  • [1] QUANTIFICATION OF PERINEURAL CANCER INVASION ON PROSTATE NEEDLE CORE BIOPSY IS USEFUL FOR RISK STRATIFICATION IN PATIENTS WITH GRADE GROUP 2 OR 3 CANCER, BUT NOT IN THOSE WITH GRADE GROUP 4-5 CANCER
    Teramoto, Yuki
    Wang, Ying
    Miyamoto, Hiroshi
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1195 - E1195
  • [2] QUANTIFICATION OF PERINEURAL INVASION BY PROSTATE CANCER ON NEEDLE CORE BIOPSY: IMPLICATION FOR RISK STRATIFICATION
    Teramoto, Yuki
    Wang, Ying
    Miyamoto, Hiroshi
    JOURNAL OF UROLOGY, 2022, 207 (05): : E139 - E139
  • [3] Quantification of Perineural Invasion by Prostate Cancer on Needle Core Biopsy: Implication for Risk Stratification
    Teramoto, Yuki
    Wang, Ying
    Miyamoto, Hiroshi
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 681 - 682
  • [4] Quantification of Perineural Invasion by Prostate Cancer on Needle Core Biopsy: Implication for Risk Stratification
    Teramoto, Yuki
    Wang, Ying
    Miyamoto, Hiroshi
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 681 - 682
  • [5] Risk Stratification by Quantification of Perineural Cancer Invasion on Prostate Needle Core Biopsy: Should It Be Counted?
    Teramoto, Yuki
    Wang, Ying
    Miyamoto, Hiroshi
    JOURNAL OF UROLOGY, 2023, 210 (04): : 639 - 648
  • [6] The Significance of Primary Biopsy Gleason 5 in Patients with Grade Group 5 Prostate Cancer
    Tilki, Derya
    Wuernschimmel, Christoph
    Preisser, Felix
    Graefen, Markus
    Huland, Hartwig
    Mandel, Philipp
    Tennstedt, Pierre
    EUROPEAN UROLOGY FOCUS, 2020, 6 (02): : 255 - 258
  • [7] Clinical Significance of Perineural Invasion in Men With Grade Group 1 Prostate Cancer on Active Surveillance
    de la Calle, Claire M.
    Mamawala, Mufaddal M.
    Landis, Patricia
    Macura, Katarzyna J.
    Trock, Bruce J.
    Epstein, Jonathan I.
    Pavlovich, Christian P.
    JOURNAL OF UROLOGY, 2023, 209 (01): : 180 - 185
  • [8] Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer
    Ranasinghe, Weranja
    Reichard, Chad A.
    Nyame, Yaw A.
    Sundi, Debasish
    Tosoian, Jeffrey J.
    Wilkins, Lamont
    Alam, Ridwan
    Achim, Mary F.
    Wang, Xuemei
    Stephenson, Andrew J.
    Klein, Eric A.
    Ross, Ashley E.
    Allaf, Mohamad E.
    Davis, John W.
    Chapin, Brian F.
    JOURNAL OF UROLOGY, 2020, 204 (04): : 748 - 753
  • [9] Confirmatory Biopsy Outcomes in Patients with Grade Group 2 Prostate Cancer: Implications for Early Management
    Leni, Riccardo
    Vertosick, Emily A.
    Liso, Nicole
    Akin, Oguz
    Carlsson, Sigrid, V
    Montorsi, Francesco
    Briganti, Alberto
    Eastham, James A.
    Fine, Samson W.
    Vickers, Andrew J.
    Ehdaie, Behfar
    EUROPEAN UROLOGY OPEN SCIENCE, 2025, 72 : 46 - 53
  • [10] Smoking increased the risk of prostate cancer with grade group ≥ 4 and intraductal carcinoma in a prospective biopsy cohort
    Tang, Bo
    Han, Cheng-Tao
    Gan, Hua-Lei
    Zhang, Gui-Ming
    Zhang, Cui-Zhu
    Yang, Wei-Yi
    Shen, Ying
    Zhu, Yao
    Ye, Ding-Wei
    PROSTATE, 2017, 77 (09): : 984 - 989
12345